A study has shown that andrographolide can inhibit the level of iNOS in cervical cancer HeLa cells, and andrographolide has anti-proliferative and pro-apoptotic properties on cervical cancer cells, but its specific pathways and mechanisms still need to be further explored (Pasha et al., 2021). Here, NOS2 is linked to cervical carcinoma.